We encourage our patients to discuss all available treatment options with their healthcare provider to determine the best approach for managing their diabetes effectively
The company states it does not currently serve Alabama, Alaska, Arkansas, Hawaii, Massachusetts, Missouri, New Mexico, New York, South Carolina, or Virginia, and notes it is "working to expand availability to more states." State availability may change
JAMA Intern Med 2022
The primary bioactive form of GLP-1 is GLP-1(736)amide a 30-amino acid C-terminally amidated peptide
Originally developed to help manage Type 2 diabetes, these medications have shown significant promise in the weight loss space, helping patients feel fuller longer, reduce cravings, and control portion sizes